|
|
(Transportation-News.com, August 24, 2018 ) Publisher's new report, United States Immuno Chemistry Market Outlook to 2024, provides key market data on the United States Immuno Chemistry market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments-Complement Deficiency Tests, Diabetes Assays, Disease Specific Immunochemistry, Endocrinology Tests, IgE Allergy Blood Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC and Vitamins Tests
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Request a Sample Report@ http://www.reportsweb.com/inquiry&RW00011298461/sample
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Report Scope:
-Market size and company share data for Immuno Chemistry market segments-Complement Deficiency Tests, Diabetes Assays, Disease Specific Immunochemistry, Endocrinology Tests, IgE Allergy Blood Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC and Vitamins Tests.
-Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
-2017 company shares and distribution shares data for each of the market segments.
-Global corporate-level profiles of key companies operating within the United States Immuno Chemistry market.
-Key players covered include Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Abbott Laboratories and Thermo Fisher Scientific Inc.
Companies Mentioned:
Siemens Healthcare GmbH
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Beckman Coulter Inc
DiaSorin S.p.A
Thermo Fisher Scientific Inc
bioMerieux SA
Bio-Rad Laboratories Inc
Ortho-Clinical Diagnostics Inc
Alere Inc
Inquire before Buying@ http://www.reportsweb.com/inquiry&RW00011298461/buying
Reasons to buy:
-Develop business strategies by identifying the key market segments poised for strong growth in the future.
-Develop market-entry and market expansion strategies.
-Design competition strategies by identifying who-stands-where in the market.
-Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
-What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.
Table of Contents:
Table of Contents 2
1.1 List of Tables 2
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About-6
2.2 Immuno Chemistry Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 8
3 Immuno Chemistry Market, United States 12
3.1 Immuno Chemistry Market, United States, Revenue ($m), 2010-2017 12
3.2 Immuno Chemistry Market, United States, Revenue ($m), 2017-2024 14
3.3 Immuno Chemistry Market, United States, Volume (Units), 2010-2017 48
3.4 Immuno Chemistry Market, United States, Volume (Units), 2017-2024 50
3.5 Immuno Chemistry Market, United States, Average Price ($), 2010-2024 84
3.6 Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), 2017 89
3.7 Immuno Chemistry Market, United States, Company Share by Revenue ($m), 2017 90
4 Overview of Key Companies in United States, Immuno Chemistry Market 92
4.1 Siemens Healthcare GmbH 92
4.2 F. Hoffmann-La Roche Ltd 92
4.3 Abbott Laboratories 92
4.4 Beckman Coulter Inc 92
4.5 DiaSorin S.p.A 93
4.6 Thermo Fisher Scientific Inc 93
4.7 bioMerieux SA 93
4.8 Bio-Rad Laboratories Inc 93
4.9 Ortho-Clinical Diagnostics Inc 94
4.10 Alere Inc 94
5 Immuno Chemistry Market Pipeline Products 95
6 Financial Deals Landscape 98
6.1 Acquisition 98
6.2 Debt Offerings 99
6.3 Equity Offerings 136
6.4 Merger 153
6.5 Partnerships 154
6.6 Venture Financing 156
7 Recent Developments 163
7.1 Corporate Communications 163
7.2 Financial Announcements 194
7.3 Government and Public Interest 297
7.4 Legal And Regulatory 299
7.5 Other Significant Developments 307
7.6 Product News 316
7.7 Strategy And Business Planning 323
8 Appendix 329
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
